Hennion & Walsh Asset Management »

Protagonist Therapeutics shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 35k 28.93
2023-12-31 $781k 34k 22.93
2023-09-30 $528k 32k 16.68
2023-06-30 $461k 17k 27.59

More positions owned by Hennion & Walsh Asset Management

Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Wisdomtree Tr Intl Qulty Div (IQDG)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Investment Grade (IGEB)
Wisdomtree Tr Us S Cap Qty Div (DGRS)
Nuveen Div. Advantage Muni. Fund (NAD)
Ishares Core Msci Emkt (IEMG)
Nuveen Insured Tax-Free Adv Munici (NEA)
Eli Lilly & Co. (LLY)
Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)
Global X Fds Us Pfd Etf (PFFD)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Franklin Templeton Etf Tr Ftse Japan Etf (FLJP)

View all positions for Hennion & Walsh Asset Management

Top funds holding Protagonist Therapeutics

BVF
Vanguard Group
Point72 Asset Management
Kynam Capital Management
Cowen And Company
Deutsche Bank Aktiengesellschaft
T. Rowe Price Associates
Dimensional Fund Advisors
683 Capital Management
Candriam Luxembourg S.C.A.
Goldman Sachs Group
Charles Schwab Investment Management
Citadel Advisors
Jpmorgan Chase & Co
Gratus Capital

View all funds holding Protagonist Therapeutics